Incyte Corporation
|
Route 141 & Henry Clay Road
Building E336
Wilmington, DE 19880
United States |
| Tel: |
1/302.498.6700 |
| URL: |
http://www.incyte.com |
|
| Formerly known as: |
| Incyte Genomics Inc. |
 |
| Primary Symbols & Exchanges: |
| INCY - NASDAQ |
| - Munich |
|
|
| Primary Industry: |
| Business Services |
|
|
|
|
Thomson Financial Business Description:
| The Group's principal activities are to discover and develop drugs for the treatment of serious unmet medical needs. The Group is engaged in the development of proprietary small molecule drugs for the treatment of human immunodeficiency virus (HIV), diabetes, oncology and inflammation. The Group operates in the United States , Canada, Germany, Sweden, and the United Kingdom. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Incyte Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
